MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).
A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors.inspiremd.com.
To request a meeting or for more details about the conferences, please reach out to your institutional contact.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com



Đề xuất
Global Times: China helps weave a greener Asia-Pacific by turning its development gains into shared opportunities
JOYY Reports Third Quarter 2026 Unaudited Financial Results
Seventy Years of Diplomatic Ties, Masks as a New Language: Colorful Guizhou Launches China–Egypt Dialogue of Civilizations Through Theatrical Masks
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce Additional $15.0 Million PIPE Commitments from Leading Institutional Stockholders